Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

2(33.3%)

Phase 2

1(16.7%)

Phase 3

1(16.7%)

Phase 4

1(16.7%)

Phase 1

1(16.7%)

6Total

N/A(2)

Phase 2(1)

Phase 3(1)

Phase 4(1)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT07122596Phase 4Completed

EFFICACY OF PROLONGED INFUSION MEROPENEM IN CRITICALLY ILL PAEDIATRIC INTENSIVE CARE PATIENTS

Role: lead

NCT06812741Phase 3Completed

Duration of Postop Analgesia After Inguinal Hernia Surgery Treated with TAP Block Vs II/IH Nerve Block

Role: lead

NCT05817799Phase 2Completed

Impact of Hemodialysis on Plasma Carnitine Levels in Patients With End Stage Renal Disease

Role: collaborator

NCT06065956Phase 1Completed

Comparison of Hemodynamic Changes With Morphine Versus Esmolol During Induction of Anaesthesia

Role: lead

NCT05489809Not ApplicableCompleted

Endotracheal Extubation With Suctioning Versus Positive Pressure in Children After General Anaesthesia.

Role: lead

NCT05476666Not ApplicableCompleted

Peripheral Venous Pressure as an Indicator of Central Venous Pressure in Post Operative Surgical Patients: A Randomised Controlled Trial

Role: lead

All 6 trials loaded